ISRCTN00253207已完成未知
A study investigating rimonabant versus placebo in conjunction with a strict low-fat weight reduction diet in overweight and obese subjects: effects on glucose and lipid metabolism and cardiovascular risk
Belfast Health and Social Care Trust (UK)0 个研究点目标入组 24 人开始时间: 2008年9月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Both males and females, age >18 years
- •2. Body mass index (BMI) >27 kg/m^2; 1. Both males and females, age >18 years
- •2. Body mass index (BMI) >27 kg/m^2
排除标准
- •1. Pregnant women/ breastfeeding mothers
- •2. Women of childbearing age unwilling to use appropriate contraception
- •3. Subjects with history of depression or anxiety
- •4. Subjects with history of significant cardiac, renal or hepatic dysfunction
- •5. Subjects concurrently on weight loss medication; 1. Pregnant women/ breastfeeding mothers
- •2. Women of childbearing age unwilling to use appropriate contraception
- •3. Subjects with history of depression or anxiety
- •4. Subjects with history of significant cardiac, renal or hepatic dysfunction
- •5. Subjects concurrently on weight loss medication
研究者
相似试验
进行中（未招募）
不适用
A study investigating rimonabant versus placebo in conjunction with a strict low-fat weight reduction diet in overweight and obese subjects: effects on glucose and lipid metabolism and cardiovascular risk.EUCTR2008-001003-38-GBThe Royal Group of Hospitals, Belfast Trust
终止
3 期
High Density Lipoprotein TurnoverObesityNCT00408148Sanofi64
终止
3 期
Japanese Study With Rimonabant in Obese Type 2 Diabetic Patients With Oral Anti-diabetic DrugDiabetes Mellitus Type 2ObesityNCT00478595Sanofi458
终止
3 期
Japanese Study With Rimonabant in Obese Type 2 Diabetic Patients on Diet and ExerciseDiabetes Mellitus Type 2ObesityNCT00478972Sanofi321
终止
3 期
An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients With Type 2 DiabetesFatty LiverNCT00577148Sanofi89